Study highlights the benefits and potential risks of ADHD medication, revealing that stimulants like amphetamines and methylphenidate reduce the risk of psychiatric hospitalization and improve long-term employment outcomes, though concerns about adverse effects such as increased heart rate and potential for triggering psychosis or mania remain.
AstraZeneca fleshes out pivotal data on $930M rare blood disorder drug it wants to pair with Soliris, Ultomiris
AstraZeneca says its add-on pill for a rare blood disorder known as paroxysmal nocturnal hemoglobinuria, or PNH, helped patients already taking Ultomiris or Soliris produce
June 9, 2023